FindTrial
Sign In

Clinical trial of potassium channel disease caused by KCNJ16 gene mutation

Tubulopathy, Sensorineural Deafness, Osteoporosis, Hypothyroidism, Hypoparathyroidism and KCNJ16 Mutation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048820
Enrollment
Unknown
Registered
2021-07-17
Start date
2019-12-20
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypokalemia

Interventions

proband:None
verifier:None

Sponsors

The First Affiliated Hospital, Third Military Medical University (Army Medical University), Gaotanyan Street, Shapingba District, Chongqing, China.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Voluntary test and informed consent of all family members living, including patients and their parents, based on the patient pedigrees

Exclusion criteria

Exclusion criteria: According to the patient pedigree, all family members present, including patients and their parents, refused to sign informed consent to participate in the trial

Design outcomes

Primary

MeasureTime frame
KCNJ16 gene mutation site;—

Countries

China

Contacts

Public ContactHu Jiongyu

Endocrinology Department, First Affiliated Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

jiongyuhu@163.com+86 1336002163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026